Marrone Bio completes second stock offering, raises $40 million

Published: Wednesday, Jun. 11, 2014 - 1:55 pm

Marrone Bio Innovations completed a $40 million stock offering Wednesday, the second time in less than a year it has raised millions from the investing public.

The Davis biotech company said its stock offering was priced at $9.50 a share. A total of 5.175 million shares were sold, including 600,000 shares by a Singapore financial firm that was an investor in Marrone. Investors paid a total of $49 million for the shares. Deducting underwriting expenses and the proceeds to the Singapore firm, Marrone took around $40 million from the offering.

The deal means Marrone, a maker of environmentally-friendly pesticides, has tapped the public stock market for a combined $105 million in the past ten months. Its initial public offering took place last August.

Marrone’s share price closed at $10.76, down 19 cents, on the Nasdaq global market.

The company has said it will use the proceeds of the stock offering to speed up product development and commercialization, and to complete a manufacturing facility in Michigan.

Call The Bee’s Dale Kasler, (916) 321-1066. Follow him on Twitter @dakasler.

Read more articles by Dale Kasler

Sacramento Bee Job listing powered by
Quick Job Search
Sacramento Bee Jobs »
Used Cars
Dealer and private-party ads


Price Range:
Search within:
miles of ZIP

Advanced Search | 1982 & Older